Lateral Flow Assays Market to Grow at a CAGR of 7.0% During 2026-2035
Lateral flow assays market is driven by the increasing demand for rapid point-of-care diagnostic solutions, rising prevalence of infectious and chronic diseases, and growing adoption of home-based testing kits globally. The expanding use of lateral flow assays in clinical testing, veterinary diagnostics, and pharmaceutical research is further supporting market growth significantly. In addition, technological advancements in multiplex detection assays, increasing investments in diagnostic infrastructure, and the growing integration of mobile readers and digital healthcare solutions are accelerating the adoption of lateral flow assay products across healthcare and biotechnology sectors.
Browse the full report description of “Lateral Flow Assays Market Size, Share & Trends Analysis By Product (Kits & Reagents, Lateral Flow Readers, and Mobile Readers), By Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assay), By Application (Clinical testing, Veterinary Diagnostics), By End-User (Hospitals and Diagnostic Centres, Home Care, Pharmaceuticals and Biotechnology Companies) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/lateral-flow-assays-market
Integrated lateral flow diagnostic solutions segment is expected to account for a major market share in 2025
Integrated lateral flow diagnostic solutions are expected to hold a major market share in 2025, primarily due to the increasing demand for rapid, cost-effective, and easy-to-use diagnostic technologies across healthcare, veterinary, food safety, and environmental monitoring applications. These solutions are widely adopted for point-of-care testing because of their fast turnaround time, portability, and ability to support decentralized diagnostic workflows. The strategic partnership formed between BBI Solutions and Lateral Dx in December 2025 highlights the growing industry focus on providing integrated lateral flow diagnostic development and manufacturing capabilities for multiple end-use sectors. Rising demand for scalable rapid testing technologies and increasing investments in decentralized diagnostics are expected to significantly contribute to the growth of the integrated lateral flow diagnostic solutions segment.
Avian flu lateral flow testing segment is expected to account for a major market share in 2025
Avian flu lateral flow testing solutions are expected to hold a major market share in 2025 owing to the increasing need for rapid infectious disease detection and surveillance across both human and animal healthcare sectors. These diagnostic kits enable quick and efficient identification of avian influenza infections, supporting disease control measures and reducing the risk of widespread outbreaks. The co-development and commercialization partnership between Abingdon Health and Okos Diagnostics in June 2025 reflects the growing emphasis on developing advanced H5N1 lateral flow tests for bovine and human health applications. The collaboration’s focus on rapid diagnostic kits using milk and nasal-pharyngeal samples demonstrates the expanding application scope of lateral flow testing technologies in veterinary diagnostics, public health monitoring, and pandemic preparedness initiatives.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404